Indian peptide therapeutics market is anticipated to project a CAGR of 7.6%, during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs. According to the National Institute of Cancer Prevention and Research, India recorded 2.25 million cancer cases in 2018 which makes it the major cause of mortality in the country.
Get Free Sample link @ https://www.omrglobal.com/request-sample/indian-peptide-therapeutics-market
Poor economic conditions are supporting the number of mortalities caused by cancer. The absence of proper diagnostic centers for the enormous population is also the key contributing factor to the prevalence of cancer in the country. Hence, the development of peptide therapeutics across the country will significantly aid the country in battling cancer thus, driving the market growth. Moreover, improving healthcare infrastructure also enhances the peptide therapeutics market growth. As per Export.gov, the $150 billion healthcare market of India in 2018 is further expected to reach $280 billion by 2022 owing to the increased demand for specialized and quality healthcare facilities. This, in turn, is likely to create significant scope for the growth of the peptide therapeutics market.
A full report of Indian Peptide Therapeutics Market available @ https://www.omrglobal.com/industry-reports/indian-peptide-therapeutics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
India Peptide Therapeutics Market by Route of Administration
- Oral
- Parenteral
India Peptide Therapeutics Market by Application
- Cancer
- Metabolic Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others (Kidney Disorder and Autoimmune Disorder)
Company Profiles
- AstraZeneca PLC
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Flagship Biotech International Pvt. Ltd.
- GlaxoSmithKline PLC
- Hemmo Pharmaceuticals Pvt. Ltd.
- Lyotex Lifesciences Pvt Ltd.
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
The Report covers:
- Comprehensive research methodology of the Indian peptide therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Indian peptide therapeutics market.
- Insights about market determinants which are stimulating the Indian peptide therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
